1st Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Labor-Health and Human Services appropriations and asked for additional FDA funding.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, funding for specialized pharmacy resident programs, and direct reimbursement under the Medicare program.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Pharmacy PHA

H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE

Bills named: S. 296 (112th), S. 1584 (112th), H.R. 3839 (112th), H.R. 2245 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.